Richard C. Adkerson
Known title: Chairman of the Board & CEOCIK: 0001200685
Associated companies
Transaction History
| FCX | ▼ Sell | Gift | 27,693 | $0 | 3/7/2026 | View on chart |
| FCX | ▼ Sell | Tax Withholding | 25,469 | $1.6M | 2/15/2026 | View on chart |
| FCX | ▼ Sell | Open Market | 132,824 | $8.6M | 2/11/2026 | View on chart |
| FCX | ▼ Sell | Open Market | 20,136 | $1.3M | 2/11/2026 | View on chart |
| FCX | ▼ Sell | Open Market | 248,031 | $15.6M | 2/10/2026 | View on chart |
| FCX | ▲ Buy | Grant | 27,500 | $0 | 2/9/2026 | View on chart |
| FCX | ▲ Buy | Grant | 248,125 | $0 | 2/9/2026 | View on chart |
| FCX | ▼ Sell | Tax Withholding | 95,165 | $5.8M | 2/9/2026 | View on chart |
| FCX | ▼ Sell | Gift | 28,773 | $0 | 11/29/2025 | View on chart |
| FCX | ▼ Sell | Gift | 25,656 | $0 | 8/25/2025 | View on chart |
| FCX | ▼ Sell | Gift | 44,775 | $0 | 5/12/2025 | View on chart |
| FCX | ▼ Sell | Tax Withholding | 27,196 | $1.1M | 2/15/2025 | View on chart |
| FCX | ▼ Sell | Tax Withholding | 55,863 | $2.1M | 2/11/2025 | View on chart |
| FCX | ▲ Buy | Grant | 151,875 | $0 | 2/11/2025 | View on chart |
| FCX | ▲ Buy | Grant | 57,000 | $0 | 2/11/2025 | View on chart |
| FCX | ▼ Sell | Gift | 36,261 | $0 | 8/26/2024 | View on chart |
| FCX | ▼ Sell | Gift | 43,164 | $0 | 5/9/2024 | View on chart |
| FCX | ▼ Sell | Open Market | 54,771 | $2.8M | 5/6/2024 | View on chart |
| FCX | ▼ Sell | Open Market | 169,229 | $8.6M | 4/30/2024 | View on chart |
| FCX | ▲ Buy | Option Exercise | 580,000 | $11.0M | 4/29/2024 | View on chart |
| FCX | ▼ Sell | Tax Withholding | 355,622 | $18.6M | 4/29/2024 | View on chart |
| FCX | ▼ Sell | Tax Withholding | 24,113 | $897K | 2/15/2024 | View on chart |
| FCX | ▲ Buy | Grant | 78,000 | $0 | 2/6/2024 | View on chart |
| FCX | ▲ Buy | Grant | 457,303 | $0 | 2/6/2024 | View on chart |
| FCX | ▼ Sell | Tax Withholding | 179,949 | $7.0M | 2/6/2024 | View on chart |
| FCX | ▲ Buy | Option Exercise | 335,000 | $10.4M | 2/1/2024 | View on chart |
| FCX | ▼ Sell | Tax Withholding | 284,559 | $11.4M | 2/1/2024 | View on chart |
| FCX | ▼ Sell | Gift | 22,101 | $0 | 12/2/2023 | View on chart |
| FCX | ▼ Sell | Gift | 8,523 | $0 | 8/23/2023 | View on chart |
| FCX | ▼ Sell | Gift | 13,110 | $0 | 3/11/2023 | View on chart |
| FCX | ▼ Sell | Tax Withholding | 15,294 | $657K | 2/15/2023 | View on chart |
| FCX | ▼ Sell | Tax Withholding | 425,423 | $18.3M | 2/7/2023 | View on chart |
| FCX | ▲ Buy | Grant | 71,500 | $0 | 2/7/2023 | View on chart |
| FCX | ▲ Buy | Grant | 1,081,125 | $0 | 2/7/2023 | View on chart |
| FCX | ▲ Buy | Option Exercise | 450,000 | $15.8M | 1/10/2023 | View on chart |
| FCX | ▼ Sell | Tax Withholding | 387,436 | $17.3M | 1/10/2023 | View on chart |
| FCX | ▼ Sell | Gift | 56,535 | $0 | 8/19/2022 | View on chart |
| FCX | ▼ Sell | Gift | 187,800 | $0 | 3/5/2022 | View on chart |
| FCX | ▼ Sell | Tax Withholding | 27,257 | $1.2M | 2/15/2022 | View on chart |
| FCX | ▲ Buy | Grant | 71,000 | $0 | 2/7/2022 | View on chart |
| FCX | ▲ Buy | Grant | 807,380 | $0 | 2/7/2022 | View on chart |
| FCX | ▼ Sell | Tax Withholding | 315,611 | $12.1M | 2/7/2022 | View on chart |
| FCX | ▼ Sell | Open Market | 202,701 | $7.4M | 12/6/2021 | View on chart |
| FCX | ▲ Buy | Option Exercise | 81,000 | $2.0M | 12/2/2021 | View on chart |
| FCX | ▲ Buy | Option Exercise | 54,000 | $1.3M | 12/2/2021 | View on chart |
| FCX | ▲ Buy | Option Exercise | 515,000 | $8.0M | 12/2/2021 | View on chart |
| FCX | ▲ Buy | Option Exercise | 263,333 | $3.1M | 12/2/2021 | View on chart |
| FCX | ▲ Buy | Option Exercise | 210,834 | $2.5M | 12/2/2021 | View on chart |
| FCX | ▼ Sell | Tax Withholding | 718,766 | $26.7M | 12/2/2021 | View on chart |
| FCX | ▼ Sell | Gift | 107,877 | $0 | 8/13/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
FCX Grasberg on schedule amid cash flow valuation questions
Recent news highlights that Freeport-McMoRan's Grasberg operation is back on schedule, supporting its production outlook. However, market commentary questions whether the stock is priced for perfection on cash flow, with copper prices acting as a key test. The company's valuation of 33.9 times trailing earnings reflects high market expectations for cash flow delivery.
FCX Grasberg on schedule amid cash flow valuation questions. Recent news highlights that Freeport-McMoRan's Grasberg operation is back on schedule, supporting its production outlook. However, market commentary questions whether the stock is priced for perfection on cash flow, with copper prices acting as a key test. The company's valuation of 33.9 times trailing earnings reflects high market expectations for cash flow delivery.